Obesity is the most prevalent noncommunicable disease in the 21st century, associated with
triglyceride deposition in hepatocytes leading to nonalcoholic fatty liver disease (NAFLD) …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide.
Patients with NAFLD are at a higher risk of developing cardiovascular disease (CVD). In fact …

Background There is limited data on the community prevalence of non‐alcoholic fatty liver
disease (NAFLD). The present study evaluated the prevalence of NAFLD in a large number …

Background and aims There is sparse data on the prevalence of renal dysfunction in
patients with nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to …

ABSTRACT BACKGROUND: Metabolic risk factors of non alcoholic fatty liver disease
(NAFLD) in non diabetic teetotallers who constitute a definite group are not well defined …

Background: Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic
syndrome. NAFLD is considered a disease of no consequence. Data on the effect of NAFLD …

En Abstract Background and aim Recently, studies have identified patain-like
phospholipase domain containing 3 (PNPLA3), which is localized in the endoplasmic …

Background: One of the diseases assuming fast importance is non-alcoholic fatty liver
disease (NAFLD) which is a clinical syndrome characterized by predominant macrovesicular …

The Asia-Pacific region is home to more than half of the global population and accounted for
62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths due to …

Metabolic syndrome (MS) and Non-Alcoholic Fatty Liver Disease (NAFLD) spectrum
disorder share common risk factors namely obesity, hypertension, diabetes mellitus, and …